Research Results: HEALTHY Study
Researchers recently announced results from the NIDDK-led HEALTHY clinical trial, which examined whether a middle school-based intervention could lower risk factors for type 2 diabetes.
The study was conducted in schools with a high enrollment of minority children and youth from low-income families, as these populations have been particularly affected by the obesity epidemic. The intervention was found to lower the obesity rate in students at highest risk for type 2 diabetes — those who started out overweight or obese in sixth grade.
However, schools that implemented the program did not differ from comparison schools in the study’s primary outcome. Surprisingly, the prevalence of overweight and obesity in students combined had declined by 4 percent in both the intervention and control schools by the end of the three-year study. One possible explanation is that comparison schools may have independently implemented healthful changes because of increased awareness about the problem of childhood obesity fostered by the study. The HEALTHY results help inform future school-based efforts to reduce overweight and obesity in children.
For more information on the study, published in the June 27 issue of the New England Journal of Medicine, go to www.nih.gov/news/health/jun2010/niddk-28.htm.
NIDDK’s 60th Anniversary
Events surrounding NIDDK’s 60th anniversary will continue all year. See photos and video of recent events. For grantees, acknowledge Institute support by adding a slide to your presentation or label to your poster with easy downloads. Check out NIDDK presentations, panels and symposia with our calendar of events. Find these resources and more at: www.niddk.nih.gov/about-niddk/strategic-plans-reports/Pages/niddk-60-years-of-advancing-research-improve-health.aspx
From left, Dr. Charles N. Rotimi, director of the Center for Research on Genomics and Global Health, Inherited Disease Research Branch of the National Human Genome Research Institute; Dr. Suzanne Nicholas, associate professor at the University of California Los Angeles; Dr. Lawrence Agodoa, director of NIDDK's Office of Minority Health Research Coordination; Dr. Griffin P. Rodgers, director of NIDDK; and Dr. Shawna Nesbitt, president of the International Society on Hypertension in Blacks, celebrate 60 years of research through NIDDK at the July 9-10 annual ISHIB meeting in Arlington, VA.
Credit: Courtesy of the International Society on Hypertension in Blacks
NIDDK on Capitol Hill
In June, Rep. Frank Pallone, Jr. (D-N.J.), a senior member of the House Energy and Commerce Committee and chair of the Subcommittee on Health, introduced House Resolution 1444, recognizing NIDDK’s 60th anniversary. Later that month, a Congressional breakfast attended by Reps. Nita Lowey, Diana DeGette, Zack Space and Gene Green was held in honor of the anniversary.
Sponsored by advocacy and professional groups, the event honored four scientists who made major contributions toward advancing research under NIDDK’s purview. Drs. Phillip Gorden, David Nathan, and Jeffrey Gordon received NIDDK Distinguished Scientist awards and Dr. Theo Heller received an NIDDK Early Career Investigator Award (http://nihrecord.od.nih.gov/newsletters/2010/09_03_2010/story4.htm).
Also in June, Dr. Judith Fradkin, director of the Division of Diabetes, Endocrinology and Metabolic Diseases, testified on “A Way Out of the Diabetes Crisis in Indian Country and Beyond” before the Senate Committee on Indian Affairs. In July, Fradkin testified on “The Battle Against Diabetes: Progress Made; Challenges Unmet” before the House Energy and Commerce Subcommittee on Health.
In April 2010, Dr. Griffin P. Rodgers joined NIH Director Dr. Francis Collins in giving testimony on the President’s FY-2011 budget request for NIH before the House Appropriations Sub-Committee on Labor, HHS, Education, and Related Agencies (www.niddk.nih.gov/about-niddk/budget-legislative-information/Pages/budget-legislative-information.aspx).
In 2009, Rodgers testified on the progress in type 1 diabetes research
before the Senate Committee on Homeland Security and Governmental Affairs Sens. Joe Lieberman and Susan Collins held the hearing, titled “Type 1 Diabetes Research: Real Progress and Real Hope for a Cure,” in conjunction with the Juvenile Diabetes Research Foundation International biennial Children’s Congress. Also testifying were actress Mary Tyler Moore, boxing legend Sugar Ray Leonard, and singer-songwriter Nick Jonas of the Jonas Brothers, who urged Congress to continue support of type 1 diabetes research. Rodgers highlighted scientific advances made possible by the Special Statutory Funding Program for Type 1 Diabetes Research, described here: http://www.t1diabetes.nih.gov/
For testimony: Recent Advances and Future Opportunities in Type 1 Diabetes Research
For more written testimony, the President’s FY-2011 budget request for NIDDK and related information, go to: www.niddk.nih.gov/about-niddk/budget-legislative-information/Pages/budget-legislative-information.aspx
From left, actress Mary Tyler Moore, NIDDK Director Dr. Griffin Rodgers, boxing legend Sugar Ray Leonard, and singer-songwriter Nick Jonas of the Jonas Brothers urged Congress to continue support of type 1 diabetes research while testifying before the Senate Committee on Homeland Security and Governmental Affairs in 2009.
Recovery Act Update
Since Feb. 17, 2009, when President Barack Obama signed the American Recovery and Reinvestment Act into law, NIDDK staff have been working to ensure that the Institute’s share of Recovery Act funds is invested in high-quality, scientifically meritorious projects. As of Aug. 20, 2010, NIDDK has funded approximately 2,000 ARRA awards. All pending ARRA awards will be issued by the end of this fiscal year and will consume all of the $445 million that NIDDK has received. For more information, go to the NIDDK Recovery Act website: http://recovery.nih.gov.